397 related articles for article (PubMed ID: 22360297)
1. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.
Stein DM; Lindell AL; Murdock KR; Kufera JA; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
J Neurotrauma; 2012 Apr; 29(6):1140-9. PubMed ID: 22360297
[TBL] [Abstract][Full Text] [Related]
2. Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
Stein DM; Kufera JA; Lindell A; Murdock KR; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
Neurocrit Care; 2011 Apr; 14(2):200-7. PubMed ID: 21210304
[TBL] [Abstract][Full Text] [Related]
3. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
[TBL] [Abstract][Full Text] [Related]
4. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM
Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588
[TBL] [Abstract][Full Text] [Related]
5. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
[TBL] [Abstract][Full Text] [Related]
6. Use of serum biomarkers to predict secondary insults following severe traumatic brain injury.
Stein DM; Lindel AL; Murdock KR; Kufera JA; Menaker J; Scalea TM
Shock; 2012 Jun; 37(6):563-8. PubMed ID: 22552017
[TBL] [Abstract][Full Text] [Related]
7. Multiple indicators model of long-term mortality in traumatic brain injury.
Gradisek P; Osredkar J; Korsic M; Kremzar B
Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
9. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H
J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
[TBL] [Abstract][Full Text] [Related]
10. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB
J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968
[TBL] [Abstract][Full Text] [Related]
11. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
Ahadi R; Khodagholi F; Daneshi A; Vafaei A; Mafi AA; Jorjani M
Spine (Phila Pa 1976); 2015 Jul; 40(14):E823-30. PubMed ID: 25341992
[TBL] [Abstract][Full Text] [Related]
13. GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.
Papa L; Silvestri S; Brophy GM; Giordano P; Falk JL; Braga CF; Tan CN; Ameli NJ; Demery JA; Dixit NK; Mendes ME; Hayes RL; Wang KK; Robertson CS
J Neurotrauma; 2014 Nov; 31(22):1815-22. PubMed ID: 24903744
[TBL] [Abstract][Full Text] [Related]
14. Neurological injury markers in children with septic shock.
Hsu AA; Fenton K; Weinstein S; Carpenter J; Dalton H; Bell MJ
Pediatr Crit Care Med; 2008 May; 9(3):245-51. PubMed ID: 18446104
[TBL] [Abstract][Full Text] [Related]
15. In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.
Papa L; Mittal MK; Ramirez J; Ramia M; Kirby S; Silvestri S; Giordano P; Weber K; Braga CF; Tan CN; Ameli NJ; Lopez M; Zonfrillo M
J Neurotrauma; 2016 Jan; 33(1):58-64. PubMed ID: 25752485
[TBL] [Abstract][Full Text] [Related]
16. Modeling serum level of s100β and bispectral index to predict outcome after cardiac arrest.
Stammet P; Wagner DR; Gilson G; Devaux Y
J Am Coll Cardiol; 2013 Aug; 62(9):851-8. PubMed ID: 23684684
[TBL] [Abstract][Full Text] [Related]
17. S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy.
Olivecrona M; Rodling-Wahlström M; Naredi S; Koskinen LO
J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1241-7. PubMed ID: 19602473
[TBL] [Abstract][Full Text] [Related]
18. [Effects of different arterial oxygen partial pressures on serum protein S100β and neuron specific enolase during cardiopulmonary bypass in infants with cyanotic congenital heart disease].
Huang C; Nong SH; Chen JM; He SR; Chen P; Ding YQ; Cen JZ; Xu G
Zhonghua Er Ke Za Zhi; 2012 Feb; 50(2):121-5. PubMed ID: 22455636
[TBL] [Abstract][Full Text] [Related]
19. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
[TBL] [Abstract][Full Text] [Related]
20. Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury.
Berger RP; Bazaco MC; Wagner AK; Kochanek PM; Fabio A
Dev Neurosci; 2010; 32(5-6):396-405. PubMed ID: 20847541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
